Abstract
Aim: The effect of hormone levels on the stimulation of Toll-like receptor 5 (TLR5) in the bladder is unknown. We aimed to study the effect of estradiol and progesterone on TLR5 expression and function in human bladder epithelial cells. Methods: After growing to near confluence, T24 human urinary bladder (HUB) cells were incubated in hormone-free (HF) media for 72 hours. Human urinary bladder cells were then incubated in (1) HF media, (2) estradiol media, (3) progesterone media, or (4) media containing estradiol and progesterone at physiologic concentrations. Following flagellin exposure, cells and media were collected. Toll-like receptor 5 expression and stimulated cytokine release were analyzed using enzyme-linked immunosorbent assays. Results were normalized with cellular protein assays. A TLR5 antagonist was used to confirm that stimulation from flagellin was mediated by TLR5 signaling. Results: Cultured HUB cells express TLR5 protein. Estradiol and progesterone environments suppress TLR5 expression compared to HF environment. The function of TLR5 was measured by interleukin 6 (IL-6) and monocyte chemoattractant protein 1 production after flagellin exposure. Interleukin 6 production was 75% higher in the estradiol than progesterone environment. The progesterone environment produced IL-6 levels twice that observed in HF and combined estrogen-progesterone environments. Interestingly, higher TLR5 expression was associated with lower IL-6 production. Conclusion: Our study demonstrated that TLR5 expression and functional activity as measured by IL-6 are modulated by hormones. The increase in TLR5-associated IL-6 may play a role in increasing the rate of symptomatic urinary tract infection. Likewise, low TLR5 functional activity may dampen the response of the innate immune system, thereby lessening the likelihood of a symptomatic bladder infection.
Similar content being viewed by others
References
Smith NJ, Varley CL, Eardley I, Feather S, Trejdosiewicz LK, Southgate J. Toll-like receptor responses of normal human urothelial cells to bacterial flagellin and lipopolysaccharide. J Urol. 2011;186(3):1084–1092.
Ayari C, Bergeron A, LaRue H, Menard C, Fradet Y. Toll-like receptors in normal and malignant human bladders. J Urol. 2011;185(5):1915–1921.
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.
Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by toll-like receptor 5. Nature. 2001;410(6832):1099–1103.
Andersen-Nissen E, Hawn TR, Smith KD, et al. Cutting edge: TLR5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol. 2007;178(8):4717–4720.
Aflatoonian R, Tuckerman E, Elliott SL, et al. Menstrual cycle-dependent changes of toll-like receptors in endometrium. Hum Reprod. 2007;22(2):586–593.
Aflatoonian R, Fazeli A. Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression. J Reprod Immunol. 2008;77(1):7–13.
Foxman B. Urinary tract infection syndromes. Infect Dis Clin North Am. 2014;28(1):1–13.
Salvatore S, Salvatore S, Cattoni E, et al. Urinary tract infections in women. Eur J Obstet Gynecol Reprod Biol. 2011;156(2):131–136.
Hamilton-Miller JM. The urethral syndrome and its management. J Antimicrob Chemother. 1994;33(suppl A):63–73.
Jackson SL, Boyko IJ, Scholes D, Abraham L, Gupta K, Fihn SD. Predictors of urinary tract infection after menopause. Am J Med. 2004;117(12):903–911.
Schnarr J, Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest. 2008;38(suppl 2):50–57.
Hooton TM, Winter C, Tiu F, Stamm WE. Association of acute cystitis with the stage of menstrual cycle in young women. Clin Infect Dis. 1996;23(3):635–636.
Reid G, Brooks H, Bacon D. In vitro attachment of Escherichia coli to human uroepithelial cells: variation in receptivity during the menstrual cycle and pregnancy. J Infect Dis. 1983;148(3):412–421.
Foxman B, Gillespie B, Koopman J, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol. 2000;151(12):1194–1205.
Ikaheimo R, Siitonen A, Heiskanen T, et al. Recurrence of UTI in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis. 1996;22(1):91–99.
Hawn TR, Verbon A, Lettinga KD, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires’ disease. J Exp Med. 2003;198(10):1563–1572.
Fazeli A, Bruce C, Anumba DO. Characterization of toll-like receptors in the female reproductive tract in humans. Hum Reprod. 2005;20(5):1372–1378.
Hawn TR, Scoles D, Li SS, et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One. 2009;4(6):e5990.
Hawn TR, Scoles D, Wang H, et al. Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS One. 2009;4(12):e8300.
Wira CR, Fahey JV, Ghosh M, Patel MV, Hickey DK, Ochiel DO. Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol. 2010;63(6):544–565.
Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol. 2012;2012(Article ID 681473):1–15.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Foust-Wright, C.E., Pulliam, S.J., Batalden, R.P. et al. Hormone Modulation of Toll-Like Receptor 5 in Cultured Human Bladder Epithelial Cells. Reprod. Sci. 24, 713–719 (2017). https://doi.org/10.1177/1933719116667489
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719116667489